MEDIOLANUM PHARMACEUTICALS LTD has a total of 56 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Italy, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and medical technology are PHRONTIER S A R L, PSIVIDA INC and FIRESTONE LEIGH H.
# | Country | Total Patents | |
---|---|---|---|
#1 | Italy | 8 | |
#2 | Australia | 5 | |
#3 | Brazil | 5 | |
#4 | Canada | 5 | |
#5 | China | 5 | |
#6 | EPO (European Patent Office) | 5 | |
#7 | Hong Kong | 5 | |
#8 | Republic of Korea | 5 | |
#9 | Mexico | 5 | |
#10 | WIPO (World Intellectual Property Organization) | 5 | |
#11 | EAPO (Eurasian Patent Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Marion Pierre | 53 |
#2 | Mauriac Patrice | 51 |
#3 | Patrice Mauriac | 3 |
#4 | Pierre Marion | 3 |
Publication | Filing date | Title |
---|---|---|
BRPI0714820A2 | subcutaneous active principle release implants over a prolonged period of time | |
EA017292B1 | Subcutaneous implants releasing an active principle over an extended period of time | |
BRPI0714818A2 | subcutaneous active principle release implants over a prolonged period of time | |
BRPI0411752A | subcutaneous implants presenting limited initial release of the active principle and subsequent linearly variable | |
KR20060079146A | Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix |